Skip to content

Clinical trials

Carcinoma, Non-Small-Cell Lung trials in Hong Kong

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Country / region: Hong Kong Clear all

172 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20044
20053
20066
20076
20086
20097
20103
20113
20126
20135
20148
20159
20165
201711
201811
20199
202010
202113
20229
20237
202412
20258
20269

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed77
Active, not recruiting41
Recruiting23
Terminated22
Unknown status3
Not yet recruiting3
Suspended1
No longer available1
Approved for marketing1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals20
Hoffmann-La Roche17
AstraZeneca16
Pfizer13
Boehringer Ingelheim7
Eli Lilly and Company7
Merck Sharp & Dohme LLC6
Amgen4
Chinese University of Hong Kong4
Daiichi Sankyo4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung172
Lung Neoplasms42
Neoplasms16
Neoplasm Metastasis10
Breast Neoplasms8
Carcinoma8
Colorectal Neoplasms7
Melanoma7
Adenocarcinoma6
Brain Neoplasms6

Trials

Showing 1 to 25 of 172. Each trial links to its page on Pharma Observatory.

72 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.